Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases |
---|---|
Disease/Condition | Blood Disorders and Diseases,Hematologic Diseases,Sickle Cell,Anemia |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Caterina Minniti, MD |
Contact Name | Shuo You |
Contact Email | shuo.you@einstein.yu.edu |
Protocol Number | 2016-7119 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Hematology - Sickle Cell Disease |
Adult, Pediatric, Both | Adult |